收藏切换
Analysis on the dilemma of medical insurance access for chimeric antigen receptor T cell products
收藏切换
Shuie LI1, Jinxi DING1, 2, *, Jiaming LI1, 2, Yuqing REN1, 2, Wei LI1, 2
World Clinical Drug | 2022, 43(4) : 352 - 358
Less
收藏切换
World Clinical Drug | 2022, 43(4): 352-358
• Topic •
Analysis on the dilemma of medical insurance access for chimeric antigen receptor T cell products
Full
Shuie LI1, Jinxi DING1, 2, *, Jiaming LI1, 2, Yuqing REN1, 2, Wei LI1, 2
Affiliations
  • 1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
  • 2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
Published: 2022-04-10 doi: 10.13683/j.wph.2022.04.002
Outline
收藏切换

As a novel cancer immunotherapy, chimeric antigen receptor T cell (CAR-T) therapy has good clinical efficacy but high treatment cost. Many foreign countries have included CAR-T in the medical insurance coverage to improve its affordability, however, CAR-T has not been included in National Reimbursement Drug List (NRDL) in China. By sorting the global CAR-T treatment status and medical insurance access situation, the paper summarized three difficulties for CAR-T access to NRDL, and proposed a three-stage solution of “independent payment of commercial health insurance-cooperative payment of commercial health insurance-regular payment of medical insurance”, providing reference to solve the CAR-T coverage problem in China.

chimeric antigen receptor T cell (CAR-T)  /  treatment progression  /  medical insurance access dilemma
李水娥, 丁锦希, 李佳明, 任雨青, 李伟. 嵌合抗原受体T细胞产品医保准入困境分析. 世界临床药物, 2022 , 43 (4) : 352 -358 . DOI: 10.13683/j.wph.2022.04.002
Shuie LI, Jinxi DING, Jiaming LI, Yuqing REN, Wei LI. Analysis on the dilemma of medical insurance access for chimeric antigen receptor T cell products[J]. World Clinical Drug, 2022 , 43 (4) : 352 -358 . DOI: 10.13683/j.wph.2022.04.002
Year 2022 volume 43 Issue 4
16
5
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.04.002
  • Receive Date:2022-01-25
  • Online Date:2026-11-19
  • Published:2022-04-10
Article Data
Affiliations
History
  • Received:2022-01-25
Funding
Affiliations
    1.School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
    2.Pharmaceutical Market Access Policy Research Center, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.04.002
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT